Current atherosclerosis reports
Semaglutide and Tirzepatide for the Treatment of Obesity and Weight-Related Comorbidities: A Narrative Review.
Zeb Ijaz Saeed, Caroline M Apovian
Published: 202510.1007/s11883-025-01369-w
No abstract available for this study.